Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03808688
Recruitment Status : Active, not recruiting
First Posted : January 17, 2019
Last Update Posted : May 9, 2019
Sponsor:
Information provided by (Responsible Party):
Aerie Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : September 2019
  Estimated Study Completion Date : September 2019